nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Acid-base balance and substitution fluid during continuous hemofiltration
|
Heering, Peter |
|
1999 |
56 |
S72 |
p. S37-S40 4 p. |
artikel |
2 |
Congestive heart failure as an indication for continuous renal replacement therapy
|
Braüse, Matthias |
|
1999 |
56 |
S72 |
p. S95-S98 4 p. |
artikel |
3 |
Continuous venovenous hemodialysis treatment in critically ill patients after liver transplantation
|
Lütkes, Peter |
|
1999 |
56 |
S72 |
p. S71-S74 4 p. |
artikel |
4 |
CRRT efficiency and efficacy in relation to solute size
|
Clark, William R. |
|
1999 |
56 |
S72 |
p. S3-S7 5 p. |
artikel |
5 |
Hemofiltration treatment for sepsis: Is it time for controlled trials?
|
Rogiers, Peter |
|
1999 |
56 |
S72 |
p. S99-S103 5 p. |
artikel |
6 |
Hepatoactive substances eliminated by continuous venovenous hemofiltration in acute renal failure patients
|
Riegel, Werner |
|
1999 |
56 |
S72 |
p. S67-S70 4 p. |
artikel |
7 |
High clearance continuous renal replacement therapy with a modified dialysis machine
|
Schlaeper, Christian |
|
1999 |
56 |
S72 |
p. S20-S23 4 p. |
artikel |
8 |
Hirudin elimination by hemofiltration: A comparative in vitro study of different membranes
|
Frank, Rolf D. |
|
1999 |
56 |
S72 |
p. S41-S45 5 p. |
artikel |
9 |
Individualized drug dosage in patients treated with continuous hemofiltration
|
Keller, Frieder |
|
1999 |
56 |
S72 |
p. S29-S31 3 p. |
artikel |
10 |
Influence of hematocrit on hemostasis in continuous venovenous hemofiltration during acute renal failure
|
Stefanidis, Ioannis |
|
1999 |
56 |
S72 |
p. S51-S55 5 p. |
artikel |
11 |
Influence of renal replacement therapy on outcome of patients with acute renal failure
|
Kresse, Sven |
|
1999 |
56 |
S72 |
p. S75-S78 4 p. |
artikel |
12 |
Introduction
|
Kierdorf, Horst P. |
|
1999 |
56 |
S72 |
p. S1-S2 2 p. |
artikel |
13 |
Is cytokine removal by continuous hemofiltration feasible?
|
Sieberth, Heinz-Günter |
|
1999 |
56 |
S72 |
p. S79-S83 5 p. |
artikel |
14 |
Is there a role for continuous renal replacement therapies in patients with liver and renal failure?
|
Davenport, Andrew |
|
1999 |
56 |
S72 |
p. S62-S66 5 p. |
artikel |
15 |
Lactate- or bicarbonate-buffered solutions in continuous extracorporeal renal replacement therapies
|
Kierdorf, Horst P. |
|
1999 |
56 |
S72 |
p. S32-S36 5 p. |
artikel |
16 |
Metabolic aspects of continuous renal replacement therapies
|
Druml, Wilfred |
|
1999 |
56 |
S72 |
p. S56-S61 6 p. |
artikel |
17 |
Non-renal indications for continuous renal replacement therapy
|
Schetz, Miet |
|
1999 |
56 |
S72 |
p. S88-S94 7 p. |
artikel |
18 |
Online monitoring in continuous renal replacement therapies
|
Ronco, Claudio |
|
1999 |
56 |
S72 |
p. S8-S14 7 p. |
artikel |
19 |
Pharmacokinetic principles during continuous renal replacement therapy: Drugs and dosage
|
Böhler, Joachim |
|
1999 |
56 |
S72 |
p. S24-S28 5 p. |
artikel |
20 |
Recombinant hirudin (lepirudin) as anticoagulant in intensive care patients treated with continuous hemodialysis
|
Fischer, Karl-Georg |
|
1999 |
56 |
S72 |
p. S46-S50 5 p. |
artikel |
21 |
Tumor necrosis factor-α during continuous high-flux hemodialysis in sepsis with acute renal failure
|
Lonnemann, Gerhard |
|
1999 |
56 |
S72 |
p. S84-S87 4 p. |
artikel |
22 |
Use of adsorptive mechanisms in continuous renal replacement therapies in the critically ill
|
Tetta, Ciro |
|
1999 |
56 |
S72 |
p. S15-S19 5 p. |
artikel |